Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Novartis AG (NVS)

83.96   -2.06 (-2.39%) 02-28 16:02
Open: 83.93 Pre. Close: 86.02
High: 84.81 Low: 83.05
Volume: 4,814,699 Market Cap: 192619M
Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 85.364 - 86.183 86.183 - 86.678
Low: 81.295 - 82.375 82.375 - 83.028
Close: 82.723 - 84.479 84.479 - 85.541

Technical analysis

as of: 2020-02-28 4:31:03 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 109.12     One year: 116.61
Support: Support1: 83.05    Support2: 69.10
Resistance: Resistance1: 93.43    Resistance2: 99.84
Pivot: 93.90
Moving Average: MA(5): 87.02     MA(20): 94.28
MA(100): 91.83     MA(250): 88.71
MACD: MACD(12,26): -2.14     Signal(9): -0.61
Stochastic oscillator: %K(14,3): 2.57     %D(3): 2.33
RSI: RSI(14): 20.28
52-week: High: 99.84  Low: 74.97  Change(%): 5.0
Average Vol(K): 3-Month: 199271  10-Days: 329147

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NVS has closed above bottom band by 0.8%. Bollinger Bands are 423.7% wider than normal. The large width of the bands suggest high volatility as compared to NVS's normal range. The bands have been in this wide range for 12 bars. This is a sign that the current trend might continue.

Headline News

Fri, 28 Feb 2020 01:26:00 +0000
FDA Approves Biohaven's Migraine Treatment Nurtec ODT

Wed, 26 Feb 2020 17:00:00 +0000
Where Will Johnson & Johnson Be in 1 Year?

Wed, 26 Feb 2020 11:10:00 +0000
What to Watch When Codexis Reports 2019 Operating Results

Mon, 24 Feb 2020 20:28:00 +0000
U.S. and EU Regulators Reviewing Novartis' Leukemia Drug for Expanded Approval in Multiple Sclerosis

Sun, 23 Feb 2020 14:31:00 +0000
The Most Important Stock to Own Over the Next Decade

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2270.00
Shares Float (M) 2120.00
% Held by Insiders
% Held by Institutions 11.33
Shares Short (K) 3100
Shares Short P. Month (K)

Stock Financials

EPS 5.060
Book Value (p.s.) 24.490
PEG Ratio 2.20
Profit Margin 24.10
Operating Margin 23.32
Return on Assets (ttm) 5.4
Return on Equity (ttm) 10.6
Qtrly Rev. Growth 6.9
Gross Profit (p.s.) 15.278
Sales Per Share
EBITDA (p.s.) 6.841
Qtrly Earnings Growth -5.90
Operating Cash Flow (M) 13620.00
Levered Free Cash Flow (M) 13460.00

Stock Valuations

P/E 16.59
P/E Growth Ratio -0.02
P/BV 3.43
P/S 3.95
P/CF 13.99

Dividends & Splits

Dividend 3.040
Dividend Yield 0.04
Dividend Pay Date 2020-03-11
Ex-Dividend Date 2020-03-02
Forward Dividend 3.040
Last Split Date 2019-04-08
Last Split Ratio -3.8
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.